KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $260.0 million.

  • Organon's Shares Outstanding (Weighted Average) rose 96.19% to $260.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $260.0 million, marking a year-over-year increase of 96.19%. This contributed to the annual value of $257.0 million for FY2024, which is 70.8% up from last year.
  • As of Q3 2025, Organon's Shares Outstanding (Weighted Average) stood at $260.0 million, which was up 96.19% from $259.9 million recorded in Q2 2025.
  • Organon's Shares Outstanding (Weighted Average)'s 5-year high stood at $260.0 million during Q3 2025, with a 5-year trough of $253.5 million in Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $255.2 million (2023), whereas its average is $255.6 million.
  • Per our database at Business Quant, Organon's Shares Outstanding (Weighted Average) changed by 0.0% in 2021 and then surged by 103.04% in 2025.
  • Organon's Shares Outstanding (Weighted Average) (Quarter) stood at $253.5 million in 2021, then increased by 0.21% to $254.1 million in 2022, then rose by 0.46% to $255.2 million in 2023, then increased by 0.71% to $257.0 million in 2024, then increased by 1.14% to $260.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $260.0 million for Q3 2025, versus $259.9 million for Q2 2025 and $257.9 million for Q1 2025.